Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.620 | 0.700 | 0.0800 |
| Révision: | $1.38B | $1.17B | $156.00M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.630 | 0.690 | 0.0600 |
| Révision: | $1.32B | $1.10B | $174.00M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.620 | 0.690 | 0.0700 |
| Révision: | $1.26B | $1.13B | $159.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.490 | 0.630 | 0.1400 |
| Révision: | $1.12B | $1.01B | $236.00M |
